161 related articles for article (PubMed ID: 28454295)
1. NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferation.
Lai XB; Nie YQ; Huang HL; Li YF; Cao CY; Yang H; Shen B; Feng ZQ
Oncol Lett; 2017 Mar; 13(3):1587-1594. PubMed ID: 28454295
[TBL] [Abstract][Full Text] [Related]
2. NEK2 promotes the progression of liver cancer by resisting the cellular senescence.
Lei Q; Xia J; Feng X; Guo J; Li G; Zhou W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):153-164. PubMed ID: 35545405
[TBL] [Abstract][Full Text] [Related]
3. Effect of silencing NEK2 on biological behaviors of HepG2 in human hepatoma cells and MAPK signal pathway.
Zhang MX; Xu XM; Zhang P; Han NN; Deng JJ; Yu TT; Gan YY; He XQ; Long ZX
Tumour Biol; 2016 Feb; 37(2):2023-35. PubMed ID: 26337275
[TBL] [Abstract][Full Text] [Related]
4. Increased NEK2 in hepatocellular carcinoma promotes cancer progression and drug resistance by promoting PP1/Akt and Wnt activation.
Wen S; Liu Y; Yang M; Yang K; Huang J; Feng D
Oncol Rep; 2016 Oct; 36(4):2193-9. PubMed ID: 27509921
[TBL] [Abstract][Full Text] [Related]
5. MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma.
Fu SJ; Chen J; Ji F; Ju WQ; Zhao Q; Chen MG; Guo ZY; Wu LW; Ma Y; Wang DP; Zhu XF; He XS
Oncotarget; 2017 Aug; 8(32):52948-52959. PubMed ID: 28881785
[TBL] [Abstract][Full Text] [Related]
6. NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition.
Zhang Y; Wang W; Wang Y; Huang X; Zhang Z; Chen B; Xie W; Li S; Shen S; Peng B
Oncol Rep; 2018 Mar; 39(3):1023-1033. PubMed ID: 29399700
[TBL] [Abstract][Full Text] [Related]
7. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
[TBL] [Abstract][Full Text] [Related]
8. NEK2 serves as a prognostic biomarker for hepatocellular carcinoma.
Li G; Zhong Y; Shen Q; Zhou Y; Deng X; Li C; Chen J; Zhou Y; He M
Int J Oncol; 2017 Feb; 50(2):405-413. PubMed ID: 28101574
[TBL] [Abstract][Full Text] [Related]
9. NIMA related kinase 2 promotes gastric cancer cell proliferation
Fan WD; Chen T; Liu PJ
World J Gastroenterol; 2019 Jun; 25(23):2898-2910. PubMed ID: 31249448
[TBL] [Abstract][Full Text] [Related]
10. SOX1 functions as a tumor suppressor by antagonizing the WNT/β-catenin signaling pathway in hepatocellular carcinoma.
Tsao CM; Yan MD; Shih YL; Yu PN; Kuo CC; Lin WC; Li HJ; Lin YW
Hepatology; 2012 Dec; 56(6):2277-87. PubMed ID: 22767186
[TBL] [Abstract][Full Text] [Related]
11. NEK2 regulates stem-like properties and predicts poor prognosis in hepatocellular carcinoma.
Lin S; Zhou S; Jiang S; Liu X; Wang Y; Zheng X; Zhou H; Li X; Cai X
Oncol Rep; 2016 Aug; 36(2):853-62. PubMed ID: 27349376
[TBL] [Abstract][Full Text] [Related]
12. The effect of cell cycle and expression of cyclin B1 and cyclin C protein in hepatocellular carcinoma cell line HepG2 and SMMC-7721 after of silencing β-catenin gene.
Wang B; Xunsun ; Liu JY; Yang D; Yang LL; Kong DX; Meng XW
Hepatogastroenterology; 2012; 59(114):515-8. PubMed ID: 22024040
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of MEK suppresses hepatocellular carcinoma growth through independent MYC and BIM regulation.
Zhou X; Zhu A; Gu X; Xie G
Cell Oncol (Dordr); 2019 Jun; 42(3):369-380. PubMed ID: 30788663
[TBL] [Abstract][Full Text] [Related]
14. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway.
Zheng Y; Jiang L; Hu Y; Xiao C; Xu N; Zhou J; Zhou X
BMC Cancer; 2017 Feb; 17(1):161. PubMed ID: 28241806
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA miR143HG predicts good prognosis and inhibits tumor multiplication and metastasis by suppressing mitogen-activated protein kinase and Wnt signaling pathways in hepatocellular carcinoma.
Lin X; Xiaoqin H; Jiayu C; Li F; Yue L; Ximing X
Hepatol Res; 2019 Aug; 49(8):902-918. PubMed ID: 30945380
[TBL] [Abstract][Full Text] [Related]
16. EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β-catenin signaling.
Li Z; Xue TQ; Yang C; Wang YL; Zhu XL; Ni CF
J Cell Biochem; 2018 Dec; 119(12):10327-10337. PubMed ID: 30129142
[TBL] [Abstract][Full Text] [Related]
17. Hepatoma cell functions modulated by NEK2 are associated with liver cancer progression.
Wu SM; Lin SL; Lee KY; Chuang HC; Feng PH; Cheng WL; Liao CJ; Chi HC; Lin YH; Tsai CY; Chen WJ; Yeh CT; Lin KH
Int J Cancer; 2017 Apr; 140(7):1581-1596. PubMed ID: 27925179
[TBL] [Abstract][Full Text] [Related]
18. Preparation of an anti-NEK2 monoclonal antibody and its application in liver cancer.
Chen Q; Li H; Yang L; Wen S; Huang X; Liu J; Guo X; Hu B; Li G; He M
BMC Biotechnol; 2021 Oct; 21(1):62. PubMed ID: 34706700
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
20. Pirfenidone Inhibits Proliferation and Promotes Apoptosis of Hepatocellular Carcinoma Cells by Inhibiting the Wnt/β-Catenin Signaling Pathway.
Zou WJ; Huang Z; Jiang TP; Shen YP; Zhao AS; Zhou S; Zhang S
Med Sci Monit; 2017 Dec; 23():6107-6113. PubMed ID: 29276937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]